Zelos Therapeutics Reaches Agreement With The FDA And EMEA For A Registration Study Of ZT-031 For The Treatment Of Osteoporosis Zelos Therapeutics, Inc. has reached agreements with the U.S. Food and Drug Administration (FDA) and the European
Medicines Agency (EMEA) for a Phase 3 registration study of ZT-031 for the treatment of severe osteoporosis.
Source: www.medicalnewstoday.comPoor Bra Choice Could Be Damaging Breasts Of Some Women Some women could be damaging their breasts without realising it, according to the breast biomechanics research team at the University of Portsmouth. As well as discovering that some women's breasts could be damaged and fragile ligaments irreparably stretched by wearing the wrong bras, scientists in the Department of Sports Science have also found that women could be damaging their breasts through ignorance or embarrassment.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 PM
